Abstract
Polyacrylamide hydrogel (PAAG), an injectable, jelly-like, medical hydrogel, has been popular in some countries as a non-surgical method of mammoplasty since approximately 2000. Particularly in China, many patients underwent mammoplasty using PAAG during a 16-year period until 2006, and studies on its course and complications were also conducted. However, evidence regarding the relationship between PAAG mammoplasty and malignancy is lacking, and only a few cases have reported the possibility of this association. Herein, we present a case in which malignancy was suspected because of complications 20 years after PAAG injection mammoplasty.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
